Publications by authors named "Dmitry A Sychev"

Claim this Profile
Q
Quality of safety reports on oral anticoagulants in the Russian state pharmacovigilance database. A cross-sectional study for 2017-2022.
Aleksandr V Matveev, Sergey V Glagolev, Elena A Kruglova, Dmitry A Sychev

Int J Risk Saf Med· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Exome-wide association study of bleeding events in patients receiving direct oral anticoagulants.
Dmitry A Sychev, Anastasiia A Buianova, Sherzod P Abdullaev, Karin B Mirzaev, Vera A Belova

Sci Prog· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of Xenobiotic Detoxification Gene Polymorphisms on Steady-State Plasma Concentrations of Apixaban and the Development of Hemorrhagic Complications in Older Patients with Non-Valvular Atrial Fibrillation.
Andrey P Kondrakhin, Sherzod P Abdullaev, Ivan V Sychev, Pavel O Bochkov, Svetlana N Tuchkova, Dmitry A Sychev

Genes (Basel)· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An Investigational Study on the Role of ADME Agents' Genetic Variation on DD217 Pharmacokinetics and Safety Profile.
Dmitry A Sychev, Sherzod P Abdullaev, Anastasia V Rudik, Alexander V Dmitriev, Svetlana N Tuchkova

Pharmaceuticals (Basel)· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An analysis of Russian-produced clinical practice guidelines using the RIGHT reporting checklist: The case of direct oral anticoagulants for coronavirus disease 2019.
Elena A Baybulatova, Mikhail S Chenkurov, Elina A Korovyakova, Sergey K Zyryanov, Dmitry A Sychev

Int J Risk Saf Med· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Genetic Modulation of Silodosin Exposure and Efficacy: The Role of CYP3A4, CYP3A5, and UGT2B7 Polymorphisms in Benign Prostatic Hyperplasia Management.
Shokhrukh P Abdullaev, Maksim N Shatokhin, Pavel O Bochkov, Svetlana N Tuchkova, Oleg B Loran, Dmitry A Sychev

J Pers Med· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical and pharmacogenetic features of patients with upper gastrointestinal lesions at a multidisciplinary hospital: the role of nonsteroidal anti-inflammatory drugs.
Natalia P Denisenko, Anna S Zhiryakova, Ivan V Sychev, Alexander V Kryukov, Svetlana N Tuchkova, Dmitry A Sychev

Drug Metab Pers Ther· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacogenetic markers of development of angioneurotic edema as a secondary side effect to enalapril in patients with essential arterial hypertension.
Ivan V Sychev, Natalia P Denisenko, Anastasiya A Kachanova, Anna V Lapshtaeva, Sherzod P Abdullaev, Dmitry A Sychev

Int J Risk Saf Med· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effects of CYP2D6 allelic variants on therapy with tamsulosin in patients with benign prostatic hyperplasia.
Skokhrukh P Abdullaev, Maksim N Shatokhin, Svetlana N Tuchkova, Sherzod P Abdullaev, Oleg V Teodorovich, Dmitry A Sychev

Drug Metab Pers Ther· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacogenetic predictors of development of secondary to enalapril dry cough in hypertensive patients.
Ivan V Sychev, Natalia P Denisenko, Anastasiya A Kachanova, Anna V Lapshtaeva, Ludmila N Goncharova, Dmitry A Sychev

Drug Metab Pers Ther· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Genetic markers associated with adverse reactions of radioiodine therapy in thyroid cancer patients.
Natalia P Denisenko, Anastasia A Kachanova, Ivan V Sychev, Gregory N Shuev, Oksana M Perfilieva, Dmitry A Sychev

Drug Metab Pers Ther· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Investigating the Use of Pharmacogenetic and Pharmacometabolomic Markers to Predict Haloperidol Efficacy and Safety Rates.
Valentin Yurievich Skryabin, Mikhail Sergeevich Zastrozhin, Aleksandra Aleksandrovna Parkhomenko, Ekaterina Petrovna Pankratenko, Sergei Aleksandrovich Pozdnyakov, Dmitry Alekseevich Sychev

Hosp Pharm· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of , polymorphisms on the safety of treatment with timolol maleate in patients with glaucoma.
Larisa K Moshetova, Maria M Soshina, Ksenia I Turkina, Elena A Grishina, Zhannet A Sozaeva, Dmitry A Sychev

Drug Metab Pers Ther· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
gene polymorphisms influence on antihypertensive effectiveness and hypouricemic effect of losartan among patients with arterial hypertension: an observational study.
Irina I Sinitsina, Alexey V Boyarko, Ilyas I Temirbulatov, Dmitry A Sychev, Kristina A Akmalova

Drug Metab Pers Ther· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Genetic markers associated with adverse reactions of radioiodine therapy in thyroid cancer patients.
Natalia P Denisenko, Anastasia A Kachanova, Ivan V Sychev, Gregory N Shuev, Oksana M Perfilieva, Dmitry A Sychev

Drug Metab Pers Ther· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Association of CYP2C19 Polymorphic Markers with Cardiovascular Disease Risk Factors in Gas Industry Workers Undergoing Periodic Medical Examinations.
Dmitry Alekseevich Sychev, Olga Alexandrovna Polyakova, Zhannet Alimovna Sozaeva, Karin Badavievich Mirzaev, Olga Dmitrievna Ostroumova

High Blood Press Cardiovasc Prev· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
and impact efficacy and safety of diazepam in patients with alcohol withdrawal syndrome.
Valentin Yurievich Skryabin, Johan Franck, Volker Martin Lauschke, Mikhail Sergeevich Zastrozhin, Valery Valerievich Shipitsyn, Dmitry Alekseevich Sychev

Nord J Psychiatry· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of , and gene polymorphisms on the efficiency and safety of postoperative analgesia with ketoprofen.
Dmitry A Sychev, Tatiana E Morozova, Dmitry A Shatskiy, Nadezhda V Shikh, Evgeniya V Shikh

Drug Metab Pers Ther· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Influence of ABCB1, CYP3A5 and CYP3A4 gene polymorphisms on prothrombin time and the residual equilibrium concentration of rivaroxaban in patients with non-valvular atrial fibrillation in real clinical practice.
Dmitry Alekseevitch Sychev, Aleksey Vladimirovich Sokolov, Olga Vilorovna Reshetko, Vladimir Petrovich Fisenko, Igor Nikolaevich Sychev

Pharmacogenet Genomics· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Using the CYP3A Activity Evaluation to Predict the Efficacy and Safety of Diazepam in Patients With Alcohol Withdrawal Syndrome.
Valentin Yu Skryabin, Mikhail S Zastrozhin, Elena A Grishina, Kristina A Ryzhikova, Valery V Shipitsyn, Dmitry A Sychev

J Pharm Pract· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of CYP2D6 Polymorphism on Equilibrium Concentration of Fluoxetine in Patients Diagnosed With Major Depressive Disorder and Comorbid Alcohol Use Disorders.
Mikhail S Zastrozhin, Valentin Y Skryabin, Alexey E Petukhov, Ekaterina P Pankratenko, Elena A Grishina, Dmitry A Sychev

J Psychiatr Pract· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
MicroRNAs as novel biomarkers for rivaroxaban therapeutic drug monitoring.
Eric Rytkin, Irina V Bure, Pavel O Bochkov, Kristina A Akmalova, Karin B Mirzaev, Igor N Sychev, Dmitry A Sychev

Drug Metab Pers Ther· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The effect of and gene polymorphisms on the efficacy and safety of the combination of tramadol and ketorolac used for postoperative pain management in patients after video laparoscopic cholecystectomy.
Andranik Alexandrovich Muradian, Dmitry Alekseevich Sychev, Dmitry Alekseevich Blagovestnov, Zhannet Alimovna Sozaeva, Kristina Anatolyevna Akmalova

Drug Metab Pers Ther· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Supporting frontline clinicians in the time of the pandemic: Rapid response pharmacology team.
Karin B Mirzaev, Yury Kiselev, Dmitriy V Ivashchenko, Vitaly Otdelenov, Dmitry A Sychev

Br J Clin Pharmacol· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Olanzapine-Associated Rhabdomyolysis: A Case Report.
Valentin Y Skryabin, Michael Zastrozhin, Dmitry A Sychev

Cureus· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis